Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-12-17 | 2022-01-06 | 151347 |
APO-RASAGILINE | 0.5MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151360 |
APO-RASAGILINE | 1MG | TABLET | Resolved | 2021-12-17 | 2022-09-01 | 151367 |
APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2022-01-07 | 2022-03-21 | 152298 |
APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2022-01-07 | 2022-04-22 | 152313 |
APO-OLMESARTAN | 20MG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152324 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152329 |
APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Actual shortage | 2022-01-07 | 2022-05-06 | 152332 |
APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
APO-SIMVASTATIN | 80MG | TABLET | Resolved | 2022-01-14 | 2022-04-18 | 152776 |
MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-01-14 | 2022-01-18 | 152779 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-01-21 | 2022-03-14 | 153267 |
APO-CLOPIDOGREL | 300MG | TABLET | Resolved | 2022-01-21 | 2022-03-17 | 153271 |
APO-MIDODRINE | 5MG | TABLET | Resolved | 2022-01-21 | 2022-04-29 | 153278 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2022-01-21 | 2022-01-22 | 153285 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2022-01-21 | 2022-02-28 | 153288 |
APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
APO-TRYPTOPHAN | 1G | TABLET | Resolved | 2022-01-21 | 2022-03-09 | 153294 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2022-01-28 | 2022-02-11 | 153777 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-NORTRIPTYLINE | 10MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1145 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |